Nemaura Medical to Present at the LD Micro Main Event Conference
October 05, 2021 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
Nemaura Medical Launches Beta Version of Its Metabolic Health Program
September 29, 2021 08:30 ET
|
Nemaura Medical, Inc
MiBoKo, a noninvasive glucose sensor utilizing AI mobile application, addresses a substantial multibillion-dollar market opportunity in healthcare LOUGHBOROUGH, England, Sept. 29, 2021 (GLOBE...
Nemaura Medical Announces Commercial Agreement with UK Licensee
September 27, 2021 08:00 ET
|
Nemaura Medical, Inc
Nemaura has previously placed order for 200,000 CGMs in anticipation of commercial ramp-up Loughborough, England, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura”...
Nemaura Medical announce Professor Osama Hamdy Joins their Advisory Board
September 17, 2021 09:05 ET
|
Nemaura Medical, Inc
Loughborough, England, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Reports Financial Results and Provides Business Update for the First Fiscal Quarter Ended June 30, 2021
August 16, 2021 08:30 ET
|
Nemaura Medical, Inc
Loughborough, England, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Announces Presentation on its Licensed Why WAIT Program During the American Diabetes Association 81st Annual Scientific Sessions
June 30, 2021 09:15 ET
|
Nemaura Medical, Inc
Loughborough, England, June 30, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...